BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19536905)

  • 1. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation.
    Campbell S; Sun CL; Kurian S; Francisco L; Carter A; Kulkarni S; Parker P; Karanes C; Forman SJ; Bhatia S
    Cancer; 2009 Sep; 115(18):4127-35. PubMed ID: 19536905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation.
    McAvoy S; Baker KS; Mulrooney D; Blaes A; Arora M; Burns LJ; Majhail NS
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1231-6. PubMed ID: 20302963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents.
    Li X; Brazauskas R; Wang Z; Al-Seraihy A; Baker KS; Cahn JY; Frangoul HA; Gajewski JL; Hale GA; Hsu JW; Kamble RT; Lazarus HM; Marks DI; Maziarz RT; Savani BN; Shah AJ; Shah N; Sorror ML; Wood WA; Majhail NS
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):587-92. PubMed ID: 24388803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review.
    Tauchmanovà L; De Rosa G; Serio B; Fazioli F; Mainolfi C; Lombardi G; Colao A; Salvatore M; Rotoli B; Selleri C
    Cancer; 2003 May; 97(10):2453-61. PubMed ID: 12733144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation.
    Choi M; Sun CL; Kurian S; Carter A; Francisco L; Forman SJ; Bhatia S
    Cancer; 2008 Oct; 113(7):1580-7. PubMed ID: 18704986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation.
    Law AD; Bhella S; Pasic I; Lam W; Michelis FV; Gerbitz A; Viswabandya A; Kumar R; Lipton JH; Mattsson J; Kim DDH
    Ann Hematol; 2021 May; 100(5):1311-1319. PubMed ID: 33710366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter.
    Schulte CM; Beelen DW
    Transplantation; 2004 Oct; 78(7):1055-63. PubMed ID: 15480174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
    Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors.
    Socié G; Sélimi F; Sedel L; Frija J; Devergie A; Esperou Bourdeau H; Ribaud P; Gluckman E
    Br J Haematol; 1994 Mar; 86(3):624-8. PubMed ID: 8043445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
    Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avascular necrosis following bone marrow transplantation: a case-control study.
    Fink JC; Leisenring WM; Sullivan KM; Sherrard DJ; Weiss NS
    Bone; 1998 Jan; 22(1):67-71. PubMed ID: 9437515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation.
    Enright H; Haake R; Weisdorf D
    Am J Med; 1990 Dec; 89(6):733-8. PubMed ID: 2252042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.
    Hoffmeister PA; Hingorani SR; Storer BE; Baker KS; Sanders JE
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):515-24. PubMed ID: 19961945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases].
    Chen H; Liu KY; Liu DH; Xu LP; Han W; Chen YH; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2127-30. PubMed ID: 19080474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
    Hamilton BK; Liu Y; Hemmer MT; Majhail N; Ringden O; Kim D; Costa L; Stuart R; Alousi A; Pidala JA; Couriel DR; Aljurf M; Antin JH; Bredeson C; Cahn JY; Cairo M; Choi SW; Dandoy C; Gale RP; Gergis U; Hematti P; Inamoto Y; Kamble RT; MacMillan M; Marks DI; Nemecek E; Nishihori T; Saad A; Savani BN; Schriber J; Seo S; Socié G; Teshima T; Verdonck LF; Waller EK; Wirk M; Spellman SR; Arora M; Chhabra S
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1744-1755. PubMed ID: 31158502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.
    Goldman JM; Majhail NS; Klein JP; Wang Z; Sobocinski KA; Arora M; Horowitz MM; Rizzo JD
    J Clin Oncol; 2010 Apr; 28(11):1888-95. PubMed ID: 20212247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
    Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
    Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.
    Bhatia S; Francisco L; Carter A; Sun CL; Baker KS; Gurney JG; McGlave PB; Nademanee A; O'Donnell M; Ramsay NK; Robison LL; Snyder D; Stein A; Forman SJ; Weisdorf DJ
    Blood; 2007 Nov; 110(10):3784-92. PubMed ID: 17671231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis.
    Patel B; Richards SM; Rowe JM; Goldstone AH; Fielding AK
    Leukemia; 2008 Feb; 22(2):308-12. PubMed ID: 17989709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia.
    Wang Y; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Lee SJ; Savage SA; Gadalla SM
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1054-1058. PubMed ID: 28389255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.